EUVIMEDEUVIMED entdecken
LeserbriefFallberichtOpen Access

Tocilizumab as an effective treatment option for idiopathic orbital inflammation: a case report and literature review

Hai-Yang Zhang, Hui-Jie Zhang, Hui-Fang Zhou

International Journal of Ophthalmology · 18.01.2026 · 19 (1) · 199-201

DOI: 10.18240/ijo.2026.01.26 ↗

Kurz gefasst

Leserbrief in der Zeitschrift International Journal of Ophthalmology, erschienen am 18.01.2026. Verfasst von Hai-Yang Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Eye Health, Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, …. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • State Key Laboratory of Eye Health, Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.

Zitieren

APA

Zhang, H. Y., Zhang, H. J., & Zhou, H. F. (2026). Tocilizumab as an effective treatment option for idiopathic orbital inflammation: a case report and literature review. International Journal of Ophthalmology, 19(1), 199-201. https://doi.org/10.18240/ijo.2026.01.26

Vancouver

Zhang HY, Zhang HJ, Zhou HF. Tocilizumab as an effective treatment option for idiopathic orbital inflammation: a case report and literature review. International Journal of Ophthalmology. 2026;19(1):199-201. doi:10.18240/ijo.2026.01.26

BibTeX
@article{Zhang2026,
  author = {Zhang, Hai-Yang and Zhang, Hui-Jie and Zhou, Hui-Fang},
  title = {Tocilizumab as an effective treatment option for idiopathic orbital inflammation: a case report and literature review},
  journal = {International Journal of Ophthalmology},
  year = {2026},
  volume = {19},
  number = {1},
  pages = {199--201},
  doi = {10.18240/ijo.2026.01.26}
}
Kostenlos starten →